Interaction of arylpiperazines with the dopamine receptor D₂ binding siteSUKALOVIC, Vladimir; ZLATOVIC, Mario; ANDRIC, Deana et al.Arzneimittel-Forschung. 2005, Vol 55, Num 3, pp 145-152, issn 0004-4172, 8 p.Article

Bromocriptine reduces steatosis in obese rodent modelsDAVIS, Lisa M; ZHENGTONG PEI; TRUSH, Michael A et al.Journal of hepatology. 2006, Vol 45, Num 3, pp 439-444, issn 0168-8278, 6 p.Article

Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatumGERLACH, M; DOUBLE, K; ARZBERGER, T et al.Journal of neural transmission. 2003, Vol 110, Num 10, pp 1119-1127, issn 0300-9564, 9 p.Article

Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D₂ receptor agonist and D₁ receptor antagonist, on endotoxin-induced-uveitis and -arthritis in ratsLAENGLE, U. W; COURT, M; MARKSTEIN, R et al.Experimental and toxicologic pathology (Print). 2005, Vol 57, Num 2, pp 127-134, issn 0940-2993, 8 p.Article

Changing paradigms in the surgical and medical management of acromegalySTOLLER, Walter A.Expert review of anticancer therapy. 2006, Vol 6, Num 9, issn 1473-7140, S47-S53, SUPArticle